Trademarkia Logo

Australia

AU$
Trademark Search
RENVI

View On IPO.GOV.AU

RENVI
Removed - Not renewed: Renewal fee not paid

Last updated on 15 Apr 2021

Owner Info

AstraZeneca Pharmaceuticals LP

1800 Concord Pike,

Wilmington DE, UNITED STATES OF AMERICA

Serial Number

1387733 filed on 7 Oct 2010

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

RENVI

Classification Information

Class [005]
Pharmaceutical preparations, including pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, hypothalamic amenor Read More

Mark Details

Serial Number

1387733

Registered On

7 Oct 2010

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

30 Sept 2010

Mark Type

US

Legal History

Show more

Status DateAction Taken
15th Apr 2021IP Right Ceased correspondence sent
15th Apr 2021Status change to Removed/Ceased - Not Renewed
12th Oct 2020Renewal Overdue correspondence sent
7th Aug 2020Renewal Reminder correspondence sent
25th Mar 2013Amend Trade Mark Registration Particulars
31st Jan 2013Full Assignment - Subsequent Owner Registered Published
31st Jan 2013IP Right Name Amendment Published
24th Jan 2013Full Assignment
23rd Jan 2013Amend Name/Address
17th Jan 2013Amend Trade Mark Registration Particulars